Medical News

RSS

Celgene, Agios Pharmaceuticals form global strategic collaboration on targeting cancer metabolism

Celgene Corporation and Agios Pharmaceuticals Inc., a privately-held biotechnology company, today announced the formation of a global strategic collaboration focused on targeting cancer metabolism. The goal of the collaboration is to discover, develop, and deliver novel disease-altering therapies in oncology based on the transformational science of Agios' innovative cancer metabolism research platform. This platform is based on the concept that targeting key metabolic enzymes unique to rapidly proliferating cancer cells can "starve" the cancer.

15 Apr 2010

Repros Therapeutics announces compliance for continued listing on Nasdaq Capital Market

Repros Therapeutics Inc. today announced that it believes that it has regained compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market.

15 Apr 2010

Positive results from NovaBay Pharmaceuticals' Phase 2a trial of NVC-422

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment and prevention of antibiotic-resistant infections, today reported positive results of an open-label Phase 2a trial of NVC-422 in chronically catheterized patients with significant bacteriuria, or bacteria in the urine. The study showed that NVC-422 was well tolerated and reduced or eliminated certain pathogens in the urine.

15 Apr 2010

Exclusive licensing practices slows innovation in gene testing market

Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk, say researchers at the Duke Institute for Genome Sciences & Policy (IGSP).

15 Apr 2010

Momenta Pharmaceuticals to present data on M402 drug candidate at 101st AACR meeting

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.

15 Apr 2010

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.

15 Apr 2010

Complete Women's Imaging selects Merge Healthcare as IT partner

Merge Healthcare today announced that it was selected by Complete Women's Imaging, P.C., a designated Breast Imaging Center of Excellence by the American College of Radiology (ACR) and the Commission on Breast Imaging, to provide a complete diagnostic imaging workflow and physician reporting solution to the Atlantic Coastal Plain region of New York.

15 Apr 2010

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Despite national guidelines aimed at improving sexual health services for teenagers, most sexually active boys - even those who report high-risk sexual behaviors - still get too little counseling about HIV and other sexually transmitted infections (STIs) during their visits to the doctor, according to a study led by researchers at Johns Hopkins Children's Center.

15 Apr 2010

Texas Health, LHP form joint venture to acquire Wilson N. Jones Medical Center

Texas Health Resources, the largest health care system in North Texas in terms of patients served, and LHP Hospital Group, Inc., have formed a joint venture to acquire Wilson N. Jones Medical Center in Sherman, Texas. Texas Health will own a majority equity interest in the joint venture that owns Texas Health Presbyterian Hospital-WNJ and LHP will manage the operation of the hospital.

15 Apr 2010

Early, accurate detection of superficial bladder cancer with Olympus PDD

With Olympus photodynamic diagnosis (PDD), superficial bladder cancer can be detected earlier, easier and more accurately. Bladder cancer is diagnosed by cystoscopy, the endoscopic introduction of a light source through the urethra (transurethral) into the bladder. The imaging technology PDD uses blue light to increase the contrast between tumour tissue (red) and healthy tissue (blue).

From Evident Corporation - Life Sciences 15 Apr 2010

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Foundation Medicine, a personalized cancer medicine company that aims to bring comprehensive cancer genome analysis into routine clinical care, today announced it has completed a $25 million Series A financing led by Third Rock Ventures.

15 Apr 2010

Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma and refractory advanced colorectal cancer.

15 Apr 2010

HHS: Early retiree claim forms for new temporary program to help businesses will be ready in June

Business Insurance: The Department of Health and Human Services says that reimbursement forms to have the federal government help pay employers for early retiree health care claims will be available in June.

15 Apr 2010

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.

15 Apr 2010

ETC's BioMedical Division to introduce new BARA-MED Select monoplace hyperbaric chamber

Environmental Tectonics Corporation today announced that its BioMedical Division will be exhibiting their new BARA-MED Select monoplace hyperbaric chamber. This new chamber, which is an addition to ETC's monoplace line, includes an undercarriage gurney storage for optimized space usage and features a fourth-generation, automated computerized operating system for control and recordkeeping, a passive pressure relief mattress, SMOOTH-RIDE™, and an adjustable height gurney and computerized treatment protocols.

15 Apr 2010

Mach One acquires White Hat Brands

Mach One Corporation, a global wellness solutions company, and White Hat Brands, LLC today announced the two companies have completed a definitive agreement whereby Mach One has acquired 100% interest in the fast-growing maker of kids' health and wellness beverages, including White Hat's top-seller Dog On It® Fortified Juice Beverages.

15 Apr 2010

First Edition: April 15, 2010

In today's headlines: The jobless benefits package, including a COBRA subsidy extension and Medicare-doctor pay fix, advances in the Senate. In the House, a committee chairman cancels a hearing on business health care complaints.

15 Apr 2010

Decoding genomes from 25,000 cancer samples

The International Cancer Genome Consortium (ICGC) today set out its bold plan to decode the genomes from 25,000 cancer samples and create a resource of freely available data that will help cancer researchers around the world. The publication outlines research design and projects as well as the important ethical framework for this science.

15 Apr 2010

Tumor suppressor, Retinoblastoma, represses DNA replication genes during cellular senescence

A frequently mutated gene in human cancers is the reitnoblastoma (RB) gene, which controls a potent tumor suppression pathway.

15 Apr 2010

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

St. Joseph Health System - Humboldt County, a member of St. Joseph Health System based in Orange, Calif., was able to track potential influenza cases minutes after California health officials released new requirements regarding influenza reporting. The SJHS-HC hospitals achieved this using SafetySurveillor, a safety surveillance solution offered by the Premier healthcare alliance.

15 Apr 2010

Medical News

Celgene, Agios Pharmaceuticals form global strategic collaboration on targeting cancer metabolism

Repros Therapeutics announces compliance for continued listing on Nasdaq Capital Market

Positive results from NovaBay Pharmaceuticals' Phase 2a trial of NVC-422

Exclusive licensing practices slows innovation in gene testing market

Momenta Pharmaceuticals to present data on M402 drug candidate at 101st AACR meeting

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

Complete Women's Imaging selects Merge Healthcare as IT partner

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Texas Health, LHP form joint venture to acquire Wilson N. Jones Medical Center

Early, accurate detection of superficial bladder cancer with Olympus PDD

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine

HHS: Early retiree claim forms for new temporary program to help businesses will be ready in June

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

ETC's BioMedical Division to introduce new BARA-MED Select monoplace hyperbaric chamber

Mach One acquires White Hat Brands

First Edition: April 15, 2010

Decoding genomes from 25,000 cancer samples

Tumor suppressor, Retinoblastoma, represses DNA replication genes during cellular senescence

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News